CAR-Ms were observed in close proximity to PDOs (PDO_1 and PDO_4), infiltrating the tumor microenvironment and engaging directly with tumor cells, which underscores their capacity to specifically target HER2-positive cancer cells (Fig. 6G). This evidence concerns the gene ERBB2 and neoplasm.